Knee Injection RCT

NCT03694821 PHASE4 TERMINATED Results posted

Hypothesis: Ketorolac injection is a cost-effective adjunct in the nonoperative treatment of knee osteoarthritis (OA) compared to steroids and viscosupplementation. Aims/objectives: The objective of this randomized, controlled, double-blinded, prospective study is to assess the efficacy and cost-effectiveness of knee injection with ketorolac in the nonsurgical management of symptomatic OA compared to injections with corticosteroids and viscosupplements.

Details

Lead sponsor	UConn Health
Phase	PHASE4
Status	TERMINATED
Enrolment	18
Start date	Thu Jul 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Osteoarthritis

Interventions

• Ketorolac Tromethamine Injection
• Methylprednisolone Acetate Injection
• Hylan G-F 20

Countries

United States